Advanced search
Publication Cover
Substance Use & Misuse Volume 54, 2019 - Issue 2
Submit an article Journal homepage
719
Views
17
CrossRef citations to date
0
Altmetric
Note

Perceived Unintended Consequences of Prescription Drug Monitoring Programs

Alden Yuanhong LaiDepartment of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; View further author information
,
Katherine C. SmithDepartment of Health, Behavior & Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; View further author information
,
Jon S. VernickDepartment of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; View further author information
,
Corey S. DavisNetwork for Public Health Law, Los Angeles, California, USA; View further author information
,
G. Caleb AlexanderDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; View further author information
&
Lainie RutkowDepartment of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USACorrespondence[email protected]
View further author information
Pages 345-349 | Received 29 Oct 2017, Accepted 17 Jun 2018, Published online: 21 Nov 2018

References

  • Bachhuber, M. A., Saloner, B., LaRochelle, M., Merlin, J. S., Maughan, B. C., Polsky, D., … Murphy, S. M. (2018). Physician time burden associated with querying prescription drug monitoring programs. Pain Medicine, doi:10.1093/pm/pny053
  • Bao, Y., Pan, Y., Taylor, A., Radakrishnan, S., Luo, F., Pincus, H. A., & Schackman, B. R. (2016). Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians. Health Affairs (Project Hope), 35(6), 1045–1051. doi:10.1377/hlthaff.2015.1673
  • Centers for Disease Control and Prevention (2018). Wide-ranging online data for epidemiologic research (WONDER). Retrieved from: http://wonder.cdc.gov/
  • Davis, C. S., Johnston, J. E., & Pierce, M. W. (2015). Overdose epidemic, prescription monitoring programs, and public health: a review of state laws. American Journal of Public Health, 105(11), e9–e11. doi:10.2105/ajph.2015.302856
  • Davis, C. S., Pierce, M., & Dasgupta, N. (2014). Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011. American Journal of Public Health, 104(8), 1389–1395. doi:10.2105/ajph.2014.301923
  • Gugelmann, H., Perrone, J., & Nelson, L. (2012). Windmills and pill mills: can PDMPs tilt the prescription drug epidemic? Journal of Medical Toxicology, 8(4), 378–386. doi:10.1007/s13181-012-0273-8
  • Islam, M. M., & McRae, I. S. (2014). An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions. BMC Pharmacology and Toxicology, 15(1), 46. doi:10.1186/2050-6511-15-46
  • Lin, D. H., Lucas, E., Murimi, I. B., Jackson, K., Baier, M., Frattaroli, S., … Alexander, G. C. (2017). Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP). Addiction, 112(2), 311–319. doi:10.1111/add.13620
  • Perrone, J., & Nelson, L. S. (2012). Medication reconciliation for controlled substances—An “ideal” prescription-drug monitoring program. New England Journal of Medicine, 366, 2341–2343. doi:10.1056/NEJMp1204493
  • Radomski, T. R., Bixler, F. R., Zickmund, S. L., Roman, K. M., Thorpe, C. T., Hale, J. A., … Gellad, W. F. (2018). Physicians' perspectives regarding prescription drug monitoring program use within the department of veterans affairs: a multi-state qualitative study. Journal of General Internal Medicine, 33(8), 1253–1259. doi:10.1007/s11606-018-4374-1
  • Rutkow, L., Chang, H. Y., Daubresse, M., Webster, D. W., Stuart, E. A., & Alexander, G. C. (2015). Effect of Florida's prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Internal Medicine, 175(10), 1642–1649. doi:10.1001/jamainternmed.2015.3931
  • Rutkow, L., Smith, K. C., Lai, A. Y., Vernick, J. S., Davis, C. S., & Alexander, G. C. (2017). Prescription drug monitoring program design and function: a qualitative analysis. Drug and Alcohol Dependence, 180, 395–400. doi:10.1016/j.drugalcdep.2017.08.040
  • Rutkow, L., Turner, L., Lucas, E., Hwang, C., & Alexander, G. C. (2015). Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. Health Affairs (Project Hope), 34(3), 484–492. doi:10.1377/hlthaff.2014.1085
  • Seth, P., Scholl, L., Rudd, R. A., & Bacon, S. (2018). Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016. Morbidity and Mortality Weekly Report, 67(12), 349–358. doi:10.15585/mmwr.mm6712a1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.